Independent global B2B platform
Expert in API & CDMO market
Direct contact between you and supplier

Find, compare & contact
Doxofylline API Manufacturers & Suppliers

Real trade data

Filters

Reset current filters

Type
Production region
Qualifications
Country of origin
Contact suppliers

Located in:

China

Produced in:

China

Established in: 2004

MOQ: 1 kg

Employees: 3000

NO.2 Huangyang Road,

Yubei District, Chongqing

401120, P.R.China

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • GMP

  • CoA

Producer

Produced in:

India

Established in: 2021

MOQ: -

Employees: 19

API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides

Small quantity APIs to commercial scale

GMP and USFDA certification based on quantity, order, assignment.

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • GMP

  • CoA

  • FDA

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • coa

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • WC

  • CoA

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • coa

Located in:

China

Produced in:

China

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • CoA

  • GMP

Located in:

Italy

Produced in:

Italy

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • GMP

  • CoA

Located in:

India

Produced in:

India

MOQ: -

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • coa

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Doxofylline API 69975-86-6?

Description:
Here you will find a list of producers, manufacturers and distributors of Doxofylline. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Doxofylline 
Synonyms:
Doxophylline  
Cas Number:
69975-86-6 
DrugBank number:
DB09273 
Unique Ingredient Identifier:
MPM23GMO7Z

About Doxofylline

Some technical information about this product: Doxofylline is a methylxanthine derivative with the presence of a dioxolane group in position As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies. In contrast with other xanthine derivatives, doxofylline does not significantly bind to adenosine alpha-1 or alpha-2 receptors and lacks stimulating effects. Decreased affinity for adenosine receptors may account for the better safety profile of doxofylline compared to theophylline Unlike theophylline, doxofylline does not affect calcium influx and does not antagonize the actions of calcium channel blockers which could explain reduced cardiac adverse reactions associated with the drug The anti-asthmatic effects of doxophylline are mediated by other mechanisms, primarily through inhibiting the activities of the phosphodiesterase (PDE) enzyme.

More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.

Doxofylline is a type of Xanthine derivates


Xanthine derivatives are a crucial subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a significant role in the development of various medications. Xanthine derivatives are chemical compounds derived from xanthine, a purine base found in various biological systems.

These derivatives possess pharmacological properties that make them valuable for the treatment of numerous medical conditions. The most notable xanthine derivative is caffeine, a widely consumed psychoactive substance with stimulant effects on the central nervous system. Caffeine is commonly found in coffee, tea, and certain soft drinks.

Apart from caffeine, other xanthine derivatives, such as theophylline and theobromine, also exhibit distinct therapeutic properties. Theophylline is utilized for the treatment of respiratory disorders, including asthma and chronic obstructive pulmonary disease (COPD). It functions by relaxing the smooth muscles in the airways, thereby facilitating easier breathing. Theobromine, on the other hand, is found in cocoa products and is known for its mild diuretic effects.

Xanthine derivatives exert their pharmacological effects by competitively inhibiting the action of enzymes called phosphodiesterases. This inhibition leads to increased levels of cyclic adenosine monophosphate (cAMP), resulting in various physiological responses, including bronchodilation and increased heart rate.

In conclusion, xanthine derivatives, including caffeine, theophylline, and theobromine, are essential pharmaceutical ingredients with diverse applications in the medical field. Their unique properties and mechanisms of action make them valuable components in medications for respiratory disorders, cardiovascular conditions, and other therapeutic purposes.


Doxofylline (Xanthine derivates), classified under Respiratory Tract Agents


Respiratory Tract Agents are a vital category of pharmaceutical APIs (Active Pharmaceutical Ingredients) designed to treat respiratory conditions and diseases. These agents are specifically formulated to target the respiratory system, which includes the lungs, airways, and nasal passages. They play a crucial role in managing various respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.

Respiratory Tract Agents encompass a wide range of medications, including bronchodilators, corticosteroids, antihistamines, and mucolytics. Bronchodilators are commonly used to relieve airway constriction and facilitate smooth breathing by relaxing the muscles in the airways. Corticosteroids help reduce inflammation in the respiratory system, alleviating symptoms and preventing exacerbations. Antihistamines work by blocking histamine receptors, thus mitigating allergic reactions that often impact the respiratory tract. Mucolytics aid in loosening and thinning mucus, making it easier to expel from the airways.

These APIs are developed through rigorous research and development processes, ensuring their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers rely on advanced technologies and stringent quality control measures to produce high-quality Respiratory Tract Agents. These APIs are subsequently incorporated into various dosage forms, including inhalers, nasal sprays, nebulizers, and oral medications.

Respiratory Tract Agents are essential in the management of respiratory conditions, providing relief from symptoms, improving lung function, and enhancing the overall quality of life for patients. They are prescribed by healthcare professionals and often used in combination therapies to achieve optimal results. As respiratory disorders continue to affect a significant portion of the global population, the development and availability of effective Respiratory Tract Agents play a vital role in addressing these health challenges and improving patient outcomes.



Doxofylline manufacturers | traders | suppliers

We have 8 companies offering Doxofylline produced in 3 different countries.

Get in contact with the supplier of your choice:

  • Fuan Pharmaceutical (Group) Co., LTD. from China, product country of origin China
  • SETV Global from India, product country of origin India
  • Unnati Pharmaceuticals Pvt Ltd from India, product country of origin India
  • Bakul Pharma from India, product country of origin India
  • Aquatic Remedies Pvt Ltd from India, product country of origin India
  • Zhejiang Changming from China, product country of origin China
  • ABC Farmaceutici from Italy, product country of origin Italy
  • Humble Healthcaare from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.